Study findings on mineral excipient for enhanced ODTs
In a recent study, scientists confirmed the ability of Omyapharm to formulate orally disintegrating tablets (ODTs) with enhanced mouthfeel and…
Pharmaceuticals, Biotechnology and Life Sciences
In a recent study, scientists confirmed the ability of Omyapharm to formulate orally disintegrating tablets (ODTs) with enhanced mouthfeel and…
Allerganhas launched ‘BC Trivia’ featuring actress and new ambassador Shay Mitchell – a fun and engaging trivia quiz designed to…
Schreiner MediPharm developed a smart blister pack for a multinational pharmaceutical corporation, for digital patient compliance monitoring to enhance medication…
Alkermes has received a $50 million payment from Biogen after it reviewed the preliminary gastrointestinal tolerability data from the ongoing…
The U.S. Food and Drug Administration has approved Mylan’s Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance…
Bayer plans to complete the acquisition of Monsanto on June, 7, doubling the size of its agriculture business, the company…
Novartis on Sunday announced positive results from the third Phase III trial of Kisqali in advanced or metastatic breast cancer.
FibroGen, a biopharmaceutical company, on Monday said the results from the Phase 1/2 clinical trial, testing pamrevlumab in combination with…
Celgene Corporation’s study testing Revlimid on patients with previously untreated follicular lymphoma showed that treatment with a chemotherapy-free R2 regimen offered numerically…
Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval for Novartis’s Aimovig…